Cohort PLC
LSE:CHRT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cohort PLC
LSE:CHRT
|
UK |
|
S
|
Svas Biosana SpA
MIL:SVS
|
IT |
|
U
|
UBE Corp
DUS:UBE
|
JP |
|
T
|
Toray Industries Inc
DUS:TOR1
|
JP |
|
Mastercraft Boat Holdings Inc
NASDAQ:MCFT
|
US |
|
NextCell Pharma AB
F:65G
|
SE |
|
C
|
Cohort PLC
F:C7K
|
UK |
|
I
|
Ingevec SA
SGO:INGEVEC
|
CL |
|
A
|
Accenture PLC
XMUN:CSA
|
IE |
|
Nephros Inc
NASDAQ:NEPH
|
US |
|
D
|
Dohome PCL
SET:DOHOME
|
TH |
|
T
|
Tsakos Energy Navigation Ltd
F:TK41
|
GR |
|
U
|
United Therapeutics Corp
XMUN:UTH
|
US |
|
P
|
Pitney Bowes Inc
F:PBW
|
US |
Intrinsic Value
The intrinsic value for Cohort PLC (CHRT) under the Base Case is hidden
GBX.
Compared with the current market price of 1 158 GBX, the stock appears hidden
.
Do our valuations actually work? See backtest results .
CHRT looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with CHRT’s past valuations and how the stock performed after similar periods.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Cohort PLC.
The intrinsic value for Cohort PLC (CHRT) under the Base Case is hidden GBX.
Compared with the current market price of 1 158 GBX, the stock appears hidden.
